iShares Biotechnology ETF $IBB Shares Sold by PFG Advisors

PFG Advisors lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 60.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,193 shares of the financial services provider’s stock after selling 3,359 shares during the period. PFG Advisors’ holdings in iShares Biotechnology ETF were worth $370,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Retirement Income Solutions Inc. acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $200,000. Q3 Asset Management acquired a new position in iShares Biotechnology ETF during the 4th quarter worth approximately $3,999,000. TD Waterhouse Canada Inc. grew its holdings in iShares Biotechnology ETF by 1,480.8% during the 4th quarter. TD Waterhouse Canada Inc. now owns 23,680 shares of the financial services provider’s stock worth $3,996,000 after acquiring an additional 22,182 shares in the last quarter. Belpointe Asset Management LLC grew its holdings in iShares Biotechnology ETF by 4.2% during the 4th quarter. Belpointe Asset Management LLC now owns 13,326 shares of the financial services provider’s stock worth $2,249,000 after acquiring an additional 537 shares in the last quarter. Finally, Sterling Investment Counsel LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth approximately $221,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.0%

NASDAQ IBB opened at $169.78 on Friday. iShares Biotechnology ETF has a 52 week low of $116.25 and a 52 week high of $179.64. The firm has a 50 day moving average of $170.35 and a two-hundred day moving average of $167.95.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.